4//SEC Filing
Gilad Oren 4
Accession 0001104659-24-111031
CIK 0001781983other
Filed
Oct 23, 8:00 PM ET
Accepted
Oct 24, 8:30 AM ET
Size
6.7 KB
Accession
0001104659-24-111031
Insider Transaction Report
Form 4
Gilad Oren
DirectorPresident/CEO
Transactions
- Purchase
Common Stock
2024-10-23$3.92/sh+500$1,958→ 333,395 total
Holdings
- 600(indirect: By Son)
Common Stock
- 1,200(indirect: By Daughter)
Common Stock
Footnotes (2)
- [F1]The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.91 to $3.92, inclusive. The reporting person undertakes to provide to the issuer or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth herein.
- [F2]The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.
Documents
Issuer
Aprea Therapeutics, Inc.
CIK 0001781983
Entity typeother
Related Parties
1- filerCIK 0001929300
Filing Metadata
- Form type
- 4
- Filed
- Oct 23, 8:00 PM ET
- Accepted
- Oct 24, 8:30 AM ET
- Size
- 6.7 KB